For Year 2025-26, Sun Pharmaceutical Industries reports the following shareholding: Total Promoters at 54.48%, Mutual Fund at 12.09%, Insurance at 6.57%, Foreign Institutional Investors at 16.12%, Domestic Institutional Investors at 2.15%, and Retail at 8.58%. This breakdown provides a quick snapshot of ownership distribution for Sun Pharmaceutical Industries in 2025-26.